After the fifth dose of the diphtheria, tetanus, acellular pertussis vaccine, protection against whooping cough waned after five years, U.S. researchers say. Lead author Dr. Nicola Klein, co-director of the Kaiser Permanente Vaccine Study Center, said the fifth dose of DTaP vaccine is routinely given to children ages 4-6 prior to starting kindergarten. Klein and colleagues compared 277 children, ages 4-12, who were positive for whooping cough, or pertussis, with 3,318 children who were negative for pertussis and separately with 6,086 matched controls. They assessed the risk of pertussis in children from 2006 to 2011 in California relative to the time since the fifth dose of DTaP. The study, published in the New England Journal of Medicine, found protection from pertussis after the fifth dose of DTaP vaccine waned more than 40 percent each year. However, if the initial effectiveness of the fifth dose of DTaP was 95 percent, its effectiveness would decrease to 71 percent after five years, but if the initial effectiveness was 90 percent, it would decline to 42 percent after five years, the study said. The findings suggest that whooping cough control measures may need to be reconsidered," Klein said in a statement. "Prevention of future outbreaks may be best achieved by developing new pertussis-containing vaccines or reformulating current vaccines to provide long-lasting immunity."
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor